Monographie - Amphotericin B lipid complex

Ultimele actualizari :
19/11/2024

Amphotericin B lipid complex

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abelcet

Argentina, Australia, Austria, Belgia, Brazilia, Canada, Danemarca, Finlanda, Franta, Germania, Grecia, Irlanda, Italia, Luxemburg, Malaezia, Marea Britanie, Mexic, Norvegia, Olanda, Peru, Portugalia, Romania, Spania, SUA, Suedia, Ungaria

Bibliografie : Amphotericin B lipid complex

	tip	publicare
1510	carte	AHFS Formulary service 2000 Bethesda - 3546 p
2247	ziar	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262	ziar	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3254	ziar	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332	Laborator	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3644	Laborator	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3828	poster	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	poster	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	ziar	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44

Mentions Légales